# A Study of ATI-50002 Topical Solution for the Treatment of Vitiligo

> **NCT03468855** · PHASE2 · COMPLETED · sponsor: **Aclaris Therapeutics, Inc.** · enrollment: 34 (actual)

## Conditions studied

- Vitiligo

## Interventions

- **DRUG:** ATI-50002 topical solution

## Key facts

- **NCT ID:** NCT03468855
- **Lead sponsor:** Aclaris Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-19
- **Primary completion:** 2019-10-16
- **Final completion:** 2019-10-16
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2020-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03468855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03468855, "A Study of ATI-50002 Topical Solution for the Treatment of Vitiligo". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03468855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*